MichaelAnthonyBalaticoMD

Cytopathology, Anatomic Pathology, Clinical Pathology

Physician

Dr. Balatico is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
15 N Medical Dr
Ste 1100
Salt Lake City, UT 84112
Phone+1 801-581-2121

PubMed

Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment.
Eric A Smith, Rachel L Belote, Nelly M Cruz, Tarek E Moustafa, Carly A Becker
Journal of Experimental & Clinical Cancer Research. 2024-12-03
1 citations
Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment.
Eric A Smith, Rachel L Belote, Nelly M Cruz, Tarek E Moustafa, Carly A Becker
Biorxiv. 2024-06-17
Male Invasive Lobular Breast Cancer: Clinicopathologic Features Including Recurrence Score Results From a Population-Based Database.
Michael Balatico, Ana L Ruano, Allison S Cleary, Lesley Lomo, H Evin Gulbahce
Archives of Pathology & Laboratory Medicine. 2024-03-01